Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 10, Number 2—February 2004


THEME ISSUE
2004 SARS Edition
SARS Transmission

SARS-associated Coronavirus Transmission, United States

Elmira T. Isakbaeva*Comments to Author , Nino Khetsuriani*, R. Suzanne Beard*, Angela Peck*, Dean D. Erdman*, Stephan S. Monroe*, Suxiang Tong*, Thomas G. Ksiazek*, Sara Lowther*†, Indra Pandya Smith*, Larry J. Anderson*, Jairam Lingappa*, Marc-Alain Widdowson*, and other members of the SARS Investigation Group
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †McKing Consulting, Atlanta, Georgia, USA

Main Article

Table 3

SARS-CoV antibodies as determined by enzyme-linked immunosorbent assay in seven confirmed SARS case-patients, by number of days after illness onset, United States, 2003a

Case-patient Days after illness onset SARS-CoV antibodiesb
Patient 1
6
 Negative
34
 1,600
Patient 2
4
 Negative
28
 6,400
64
 6,400
Patient 3
6
 Negative
25
 6,400
46
 1,600
71
 1,600
Patient 4
2
 Negative
5
 Negative
13
 Negative
30
 6,400
Patient 5
14
 Negative
41
 1,600
Patient 6
10
 1,600
11
 1,600
15
 6,400
23
 6,400
Patient 7
11
 400
15
 1,600
18
 6,400
21
 6,400
6
 1,600
32 6,400

aSARS-CoV, severe acute respiratory syndrome–associated coronavirus.
bReciprocal of dilution.

Main Article

1Members of the SARS Investigation Group: J. McLaughlin (Alaska Division of Health); M. Romney, A. Kimura (California Department of Health Services); D. Dassey, B. Lash, D. Terashita (California-Los Angeles County Health Department); S. Klish (California-Orange County Health Care Agency); S. Cody (California-Santa Clara County Health Department); S. Farley (California-Contra County Health Department); S. Lea (California-Marin County Health Department); R. Sanderson (Florida Department of Health); J. Wolthuis (Georgia Division of Public Health); C. Allard (Mississippi Department of Health); B. Albanese (New Mexico Department of Health); B. Nivin (New York City Department of Health and Mental Hygiene); P. McCall, M. Davies (North Carolina Department of Health); M. Murphy, E. Koch (Ohio Department of Health); A. Weltman (Pennsylvania Department of Health); H. Brumund (Virginia Department of Health); C. Barton (Utah Department of Health); K. Whetstone (Southwest Utah Public Health Department); W. J. Bellini, S. Bialek, J. A. Comer, S. Emery, R. Helfand, T. Hennessy, A. James, A. LaMonte, E. C. Newbern, S. Scott, L. Simpson, A. Siwek, C. Smelser, L. Stockman, X. Lu, D. White (Centers for Disease Control and Prevention).

Page created: January 27, 2011
Page updated: January 27, 2011
Page reviewed: January 27, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external